FiercePharmaAsia—Sinopharm, Sinovac COVID vaccines; Takeda’s warning letter, $2B pipeline cull aliu Fri, 06/19/2020 – 08:06
We were surprised to read the editorial by Scally and colleagues, which criticises the UK government’s handling of […]
Shortly before noon on 5 June 2020, dozens of healthcare workers in blue scrubs and facemasks, some wearing […]
As my mother struggled with feeling isolated and lonely during lockdown in her nursing home, I continued to […]
The NHS has abandoned its plans to develop its own centralised app for contact tracing in favour of […]
Scally and colleagues’ editorial on the UK’s public health response to covid-19 is disheartening.1The BMJ, with its global […]
The firm is ‘encouraged’ by the performance of the drug, both as monotherapy and in combination with semaglutide
The drug prevented more than 90% of precancerous sporadic adenomas in trials
The selective and reversible JAK inhibitor hit all goals in the Phase III Measure Up study
WM is a rare lymphoma representing around 1% of all non-Hodgkin lymphomas